Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $1.01 USD
Change Today -0.06 / -5.61%
Volume 153.8K
DYAI On Other Exchanges
Symbol
Exchange
OTC US
As of 8:10 PM 07/2/15 All times are local (Market data is delayed by at least 15 minutes).

dyadic international inc (DYAI) Snapshot

Open
$1.06
Previous Close
$1.07
Day High
$1.07
Day Low
$0.97
52 Week High
08/18/14 - $1.87
52 Week Low
12/11/14 - $0.80
Market Cap
34.4M
Average Volume 10 Days
66.2K
EPS TTM
$-0.13
Shares Outstanding
34.0M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for DYADIC INTERNATIONAL INC (DYAI)

dyadic international inc (DYAI) Related Bloomberg News

View More Bloomberg News

dyadic international inc (DYAI) Related Businessweek News

No Related Businessweek News Found

dyadic international inc (DYAI) Details

Dyadic International, Inc., a biotechnology company, discovers, develops, manufactures, and sells enzymes and other proteins for the bioenergy, biochemical, biopharmaceutical, and industrial enzyme industries. It utilizes an integrated technology platform based on its patented and proprietary C1 microorganism, which enables the development and manufacture of enzymes and other proteins for various markets. The company licenses its patented and proprietary technologies; and provides research and development services for third parties. In addition, it manufactures and sells liquid and dry enzyme products for use in the animal feed, pulp and paper, starch and alcohol, food and brewing, textiles, and biofuels industries. The company’s C1 Platform Technology could also be used for developing and producing other biological products, such as antibodies, vaccines, proteins, and polypeptides for the biopharmaceutical industry. Dyadic International, Inc. has operations in the United States and the Netherlands. The company was founded in 1979 and is headquartered in Jupiter, Florida.

57 Employees
Last Reported Date: 03/11/15
Founded in 1979

dyadic international inc (DYAI) Top Compensated Officers

Chief Executive Officer, President, Founder, ...
Total Annual Compensation: $385.4K
Chief Operating Officer and Executive Vice Pr...
Total Annual Compensation: $195.4K
Vice President of Operations
Total Annual Compensation: $225.0K
Compensation as of Fiscal Year 2013.

dyadic international inc (DYAI) Key Developments

Dyadic International, Inc., Annual General Meeting, Jun 24, 2015

Dyadic International, Inc., Annual General Meeting, Jun 24, 2015., at 10:00 US Eastern Standard Time. Location: PGA National Resort, St. Andrews Room. Agenda: To elect two Class II directors to the company’s board of directors to serve until the company's 2018 Annual Meeting of Stockholders or until their successors are duly elected and qualified; to ratify the appointment of Mayer Hoffman McCann P.C., as the company's independent registered public accounting firm for the year ending December 31, 2015; and to transact such other business as may properly come before the annual meeting or any adjournment or postponement thereof.

Dyadic International, Inc. Announces Unaudited Consolidated Earnings Results for the First Quarter Ended March 31, 2015; Provides Financial Guidance for Fiscal 2016

Dyadic International, Inc. announced unaudited consolidated earnings results for the first quarter ended March 31, 2015. Net loss for the three month period ended March 31, 2015 was $0.4 million, or $0.1 per basic and diluted share, compared to a net loss of $1.6 million, or $0.05 per basic and diluted share, for the same period a year ago. Total revenue for the three month period ended March 31, 2015 increased 35% to approximately $4.0 million compared to $3.0 million for the same period a year ago. Net product related revenue for the three month period ended March 31, 2015 increased 41% to approximately $3.5 million compared to $2.5 million for the same period a year ago. The increase in revenue for the period was driven by growth in the animal nutrition, biogas and food markets. License fee revenue for the three month period ended March 31, 2015 increased to $0.2 million due to the Company achieving a second research milestone with BASF. Research and development revenue for the three month period ended March 31, 2015 decreased 32% to approximately $0.4 million compared to $0.5 million for the same period a year ago. The decrease in revenue for the period was due to mix and timing of project activity in commercial and government programs. Gross profit for the three month period ended March 31, 2015 increased 70% to approximately $1.6 million compared to $0.9 million for the same period a year ago. The $0.7 million increase in gross profit is attributable to (i) product related revenue growth of approximately $0.3 million, (ii) cost improvements in manufacturing, fermentation and down-stream processing of $0.4 million and (iii) the BASF research milestone of $0.2 million, (iv) partially offset by lower research & development margins due to mix and timing of commercial and government programs of $0.2 million. Loss from operations was $203,424 against $1,409,793 a year ago. As a result, the company believes that it is on track to meet its objective of attaining profitability in 2016.

Dyadic International, Inc. to Report Q1, 2015 Results on May 14, 2015

Dyadic International, Inc. announced that they will report Q1, 2015 results at 5:00 PM, US Eastern Standard Time on May 14, 2015

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
DYAI:US $1.01 USD -0.06

DYAI Competitors

Market data is delayed at least 15 minutes.

Company Last Change
EI du Pont de Nemours & Co $59.99 USD -1.44
View Industry Companies
 

Industry Analysis

DYAI

Industry Average

Valuation DYAI Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 2.5x
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales 1.5x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact DYADIC INTERNATIONAL INC, please visit www.dyadic.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.